SiBionics in Numbers

  • 56


  • 50

    Invention patents

  • 3


  • 26

    Software copyright

  • 80+

    Team members

  • 12


  • 30

    Master degrees

  • 50%

    Percentage of R&D staffs among entire full-time employees

    *As of September 2018


SiBionics is a MedTech startup specialized in the R&D and commercialization of active implantable medical devices and medical artificial intelligence. Our company is headquartered in Shenzhen with additional R&D center and offices located in Los Angeles, Beijing and Guangzhou. Our project pipeline includes Retinal Prosthesis, Continuous Glucose Monitoring, Diabetic Retinopathy Screening and Gastric Cancer Screening.

Learn More >


SiBionics has received venture capital investment of over 100 million CNY, in addition to awards and subsidies from national, provincial and municipal governments exceeding 10 million CNY. As our current projects continue to achieve important milestones, including a number of firsts in China, we are gradually building a comprehensive R&D platform from which more projects will be incubated and team developed.

Learn More >


Our growing R&D staffs at SiBionics consist of multi- and interdisciplinary talents with solid research background and extensive industry experience. Additionally, we have been developing in-house talents in areas such as design and manufacturing, quality management, enterprise resource management, intellectual property, regulatory and legal affairs as well as marketing and sales as to ensure our success in every step of product lifecycle.

Learn More >


Elevated thinking and grounded practice are what we value the most at SiBionics. It calls for translating cutting edge technology and multidisciplinary expertise into medical products and services of real value. It also challenges us to bide our time and stay grounded while doing so. Only by marrying knowledge with action, can we grow as organization and individuals and create unique societal values.                       

Learn More >